These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11122229)

  • 1. New approaches to topical therapy.
    Smith CH
    Clin Exp Dermatol; 2000 Oct; 25(7):567-74. PubMed ID: 11122229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic agents of today and the future for atopic dermatitis].
    Ikoma A
    Nihon Yakurigaku Zasshi; 2006 Dec; 128(6):411-5. PubMed ID: 17167215
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical tacrolimus: a new therapy for atopic dermatitis.
    Russell JJ
    Am Fam Physician; 2002 Nov; 66(10):1899-902. PubMed ID: 12469964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Atopic Dermatitis and Topical Therapies.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
    J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical corticosteroids versus topical inhibitors of calcineurin].
    Niedner R
    Hautarzt; 2003 Apr; 54(4):338-41. PubMed ID: 12669205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy of paediatric atopic dermatitis: an update.
    Borchard KL; Orchard D
    Australas J Dermatol; 2008 Aug; 49(3):123-34; quiz 135-6. PubMed ID: 18638218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Abramovits W; Hung P; Tong KB
    Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy of atopic dermatitis.
    Sidbury R; Hanifin JM
    Clin Exp Dermatol; 2000 Oct; 25(7):559-66. PubMed ID: 11122228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E; Burgdorf WH; Wollenberg A
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of topical therapies and the rationale for combination therapy.
    Norris DA
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S17-25. PubMed ID: 15968260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.